Response to Secukinumab on Synovitis using Power Doppler Ultrasound in Psoriatic Arthritis: 12-week Results from a Phase III Study, ULTIMATE.
Maria Antonietta D'AgostinoGeorg SchettAlejandra López-RdzLadislav ŠenoltKatalin FazekasRuben Burgos-VargasJose Maldonado-CoccoEsperanza NaredoPhilippe CarronAnne-Marie DugganPunit GoyankaMaarten BoersCorine GaillezPublished in: Rheumatology (Oxford, England) (2021)
This unique ultrasound study shows that apart from improving the signs and symptoms of PsA, IL-17A inhibition with secukinumab leads to a rapid and significant reduction of synovitis in PsA patients.
Keyphrases
- prostate cancer
- phase iii
- magnetic resonance imaging
- end stage renal disease
- ankylosing spondylitis
- newly diagnosed
- open label
- chronic kidney disease
- randomized controlled trial
- radical prostatectomy
- computed tomography
- double blind
- rheumatoid arthritis
- systemic lupus erythematosus
- ultrasound guided
- peritoneal dialysis